First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial

Gareth J. Morgan(Royal Marsden NHS Foundation Trust), Faith E. Davies(Institute of Cancer Research), Walter M. Gregory(University of Leeds), Kim Cocks(University of Leeds), Sue Bell(University of Leeds), Alex J. Szubert(University of Leeds), Nuria Navarro-Coy(University of Leeds), Mark T. Drayson(University of Birmingham), Roger G. Owen(St James's University Hospital), Sylvia Feyler(Calderdale and Huddersfield NHS Foundation Trust), A. John Ashcroft(Mid Yorkshire Hospitals NHS Trust), Fiona Ross(University of Southampton), Jenny Byrne(Nottingham University Hospitals NHS Trust), Huw Roddie(Western General Hospital), Claudius Rudin(Royal Devon and Exeter Hospital), Gordon Cook(St James's University Hospital), Graham Jackson(University of Newcastle Australia), J. Anthony Child(University of Leeds)
The Lancet
December 1, 2010
Cited by 569Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis